The primary drivers projected to drive market expansion are rising diabetes prevalence, increased diabetes awareness, various forms of insulin, and various insulin delivery systems. Insulin pump devices are compact and long-lasting. Insulin pumps are user-friendly since they can be readily configured and include an LCD screen for programme display. Furthermore, the battery compartment and reservoir compartment are both small. Insulin pumps are extremely portable, making delivery simple. Furthermore, insulin pumps reduce the number of insulin injections. In contrast, there is precise delivery of insulin. Diabetes can be better controlled by utilising insulin pumps. Diabetes' rising incidence is likely to drive growth in the insulin pump market throughout the forecast period. Furthermore, the rising prevalence of diabetes in middle and low-income countries is expected to drive growth in the Insulin Pump Market.
Major Players in the Insulin Pump Industry:
Medtronics
Medtronic provides healthcare technology solutions for complex and challenging conditions. They deliver treatments and therapies for the lungs, brain, dental, diabetes, ENT, heart, gastrointestinal, orthopedic, urinary, and women's health. The company was founded in 1949, headquartered in Minnesota, U.S. In June 2019, Medtronic and Tidepool entered into a partnership to develop an automated insulin pump system. Medtronic plans to develop a Bluetooth-enabled MiniMed pump that would be compatible with Tidepool Loop which is an open-source, automated insulin delivery app for iPhone and Apple Watch. In March 2019, Medtronic plc launched MiniMed 670G system. It is the first personalized system, which automatically delivers the insulin dose 24 hours a day, in order to avoid hypoglycaemia and hyperglycaemia. The system consist of SmartGuard Auto Mode and the continuous glucose monitor (CGM) (Guardian Sensor 3).
Braun Melsungen
Manufacturer of healthcare supplies dedicated to protecting and improving people's health. The company offers products and product systems for anesthesia, intensive care, cardiology, extracorporeal blood treatment and surgeries. The company was founded in 1838, headquartered in Melsungsen, Germany.
